DHLSX
Price
$27.87
Change
+$0.12 (+0.43%)
Updated
Jan 17 closing price
Net Assets
1.68B
WGLSX
Price
$14.62
Change
+$0.09 (+0.62%)
Updated
Jan 17 closing price
Net Assets
74.23M
Ad is loading...

DHLSX vs WGLSX

Header iconDHLSX vs WGLSX Comparison
Open Charts DHLSX vs WGLSXBanner chart's image
Diamond Hill Long-Short I
Price$27.87
Change+$0.12 (+0.43%)
VolumeN/A
Net Assets1.68B
Wasatch Long/Short Alpha Institutional
Price$14.62
Change+$0.09 (+0.62%)
VolumeN/A
Net Assets74.23M
DHLSX vs WGLSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DHLSX vs. WGLSX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHLSX is a Buy and WGLSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
DHLSX has more cash in the bank: 1.68B vs. WGLSX (74.2M). DHLSX pays higher dividends than WGLSX: DHLSX (2.02) vs WGLSX (0.00). DHLSX was incepted earlier than WGLSX: DHLSX (20 years) vs WGLSX (3 years). WGLSX is a more actively managed with annual turnover of: 75.00 vs. DHLSX (41.00). DHLSX has a lower initial minimum investment than WGLSX: DHLSX (2500) vs WGLSX (100000). WGLSX annual gain was more profitable for investors over the last year : 12.12 vs. DHLSX (5.56).
DHLSXWGLSXDHLSX / WGLSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years3 years-
Gain YTD2.6903.32281%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets1.68B74.2M2,267%
Annual Yield % from dividends2.020.00-
Returns for 1 year5.5612.1246%
Returns for 3 years-0.2242.63-1%
Returns for 5 years8.41N/A-
Returns for 10 years27.6265.1142%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVTE2.580.15
+6.17%
Aerovate Therapeutics
CMA66.100.98
+1.50%
Comerica
LOW261.062.28
+0.88%
Lowe's Companies
ADTN10.190.06
+0.59%
ADTRAN Holdings
TARS46.52-0.40
-0.85%
Tarsus Pharmaceuticals